Abstract
The glycolytic enzyme α-enolase is a plasminogen-binding protein that is generally found in the cytosolic compartment. However, α-enolase can also be expressed on cell surfaces following an inflammatory stimulus via an unknown mechanism. We investigated the effects of Streptococcus sanguinis (S. sanguinis) and the sera of patients with Behçet’s disease (BD) on the expression and distribution of α-enolase in human dermal microvascular endothelial cells (HDMECs). HDMECs were stimulated with cultured S. sanguinis and the sera of active BD patients. HDMECs incubated for 6, 12 or 24 h were harvested, and the membrane and cytoplasmic fractions of proteins were extracted. The expression and distribution of α-enolase were analyzed using subcellular fractionation and immunoblotting. Subcellular localization of α-enolase was also assessed by immunocytochemistry. S. sanguinis stimulated the expression of α-enolase in the membranous compartment of HDMECs in a dose-dependent manner. This pattern was also observed in HDMECs incubated with BD patients’ sera. Although incubation of HDMECs with sera from healthy controls increased membrane expression of α-enolase, incubation with BD sera resulted in earlier and higher expression of this glycoprotein in the cellular membrane of HDMECs. Immunocytochemistry revealed strong immunostaining of α-enolase in the cytoplasm and cytoplasmic membrane of HDMECs incubated with S. sanguinis or BD patients’ sera. In conclusions, these results indicate that S. sanguinis infection and the sera of BD patients with active disease are inflammatory stimuli that can induce membranous α-enolase expression in endothelial cells. Membrane-expressed α-enolase could potentially react with anti-α-enolase antibodies in BD patients’ sera, resulting in increased inflammation.
Similar content being viewed by others
References
Angiolella L, Facchin M, Stringaro A, Maras B, Simonetti N, Cassone A (1996) Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J Infect Dis 173:684–690
Brandenburg LO, Varoga D, Nicolaeva N et al (2008) Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptides in meningitis. J Neuropathol Exp Neurol 67:1041–1054
Capello M, Ferri-Borgogno S, Cappello P, Novelli F (2011) α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J 278:1064–1074
Cappello P, Tomaino B, Chiarle R et al (2009) An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 125:639–648
Cho SB, Lee JH, Ahn KJ, Cho S, Park YB, Lee SK, Bang D, Lee KH (2010) Identification of streptococcal proteins reacting with sera from Behçet’s disease and rheumatic disorders. Clin Exp Rheumatol 28:S31–S38
Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195–205
Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A (2000) ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett 473:47–52
Fontan PA, Pancholi V, Nociari MM, Fischetti VA (2000) Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J Infect Dis 182:1712–1721
Ghosh AK, Steele R, Ray RB (1999) Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation. Mol Cell Biol 19:2880–2886
He P, Naka T, Serada S et al (2007) Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98:1234–1240
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Kalayciyan A, Zouboulis C (2007) An update on Behçet’s disease. J Eur Acad Dermatol Venereol 21:1–10
Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K (2008) The role of streptococcal hypersensitivity in the pathogenesis of Behçet’s disease. Eur J Dermatol 18:489–498
Kolberg J, Aase A, Bergmann S, Herstad TK, Rødal G, Frank R, Rohde M, Hammerschmidt S (2006) Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. Microbiology 152:1307–1317
Lee JH, Cho SB, Bang D, Oh SH, Ahn KJ, Kim J, Park YB, Lee SK, Lee KH (2009) Human anti-alpha-enolase antibody in sera from patients with Behçet’s disease and rheumatologic disorders. Clin Exp Rheumatol 27:S63–S66
Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D (2003) Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet’s disease. Arthritis Rheum 48:2025–2035
López-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fábregas P, Jardí M, Merton E, Miles LA, Félez J (2003) Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol 72:234–242
Merkulova T, Lucas M, Jabet C (1997) Biochemical characterization of the muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem J 323:791–800
Moscato S, Pratesi F, Sabbatini A, Chimenti D, Scavuzzo M, Passatino R, Bombardieri S, Giallongo A, Migliorini P (2000) Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol 30:3575–3584
Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Büschenfelde KH, Mayet WJ (1998) Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 112:507–515
Pancholi V (2001) Multifactorial α-enolase: its role in diseases. Cell Mol Life Sci 58:902–920
Pancholi V, Chhatwal GS (2003) Housekeeping enzymes as virulence factors for pathogens. Int J Med Microbiol 293:391–401
Pancholi V, Fischetti VA (1998) Alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 273:14503–14515
Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P (2000) Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol 27:109–115
Ray R, Miller DM (1991) Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11:2154–2161
Sugahara T, Nakajima H, Shirahata S, Murakami H (1992) Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells. Cytotechnology 10:137–146
Sabbatini A, Dolcher MP, Marchini B, Chimenti D, Moscato S, Pratesi F, Bombardieri S, Migliorini P (1997) Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 15:655–658
Seweryn E, Pietkiewicz J, Bednarz-Misa IS, Ceremuga I, Saczko J, Kulbacka J, Gamian A (2009) Localization of enolase in the subfractions of a breast cancer cell line. Z Naturforsch C 64:754–758
Yokota K, Hayashi S, Araki Y, Isogai E, Kotake S, Yoshikawa K, Fujii N, Hirai Y, Oguma K (1995) Characterization of Streptococcus sanguis isolated from patients with Behçet’s disease. Microbiol Immunol 39:729–732
Yokota K, Oguma K (1997) IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behçet’s disease. Microbiol Immunol 41:925–931
Acknowledgments
Suhyun Cho, Zhenlong Zheng, and Sung Bin Cho received financial support from a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. 2010-0022927).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
S. Cho and Z. Zheng contributed equally to this work.
Rights and permissions
About this article
Cite this article
Cho, S., Zheng, Z., Cho, S.B. et al. Streptococcus sanguinis and the sera of patients with Behçet’s disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells. Arch Dermatol Res 305, 223–232 (2013). https://doi.org/10.1007/s00403-012-1298-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-012-1298-1